Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.

@article{Ravindran2000TreatmentOD,
  title={Treatment of dysthymia with sertraline: a double-blind, placebo-controlled trial in dysthymic patients without major depression.},
  author={Arun V Ravindran and Julien Daniel Guelfi and Roger M. Lane and Giovanni Battista Cassano},
  journal={The Journal of clinical psychiatry},
  year={2000},
  volume={61 11},
  pages={
          821-7
        }
}
BACKGROUND The selective serotonin reuptake inhibitor sertraline has been shown to be efficacious and well tolerated for the treatment of major depressive disorder. Relatively few trials, however, have examined the role of pharmacotherapy in dysthymia without concurrent major depression. The current investigation focuses on the use of sertraline for the treatment of dysthymia. METHOD In this 12-week, multicenter, double-blind study, 310 patients with a DSM-III-R diagnosis of dysthymic… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 16 extracted citations